Doctors Note Logo

Published on: 9/25/2026

Heart failure life expectancy by age: what the numbers really mean

Life expectancy with heart failure varies widely by age at diagnosis, with research generally showing that about 75 to 80 percent of people survive the first year and roughly half survive five years, while younger adults often live substantially longer than those averages imply. Survival estimates tend to decline with each decade of age, but stage, ejection fraction, kidney function, blood pressure, and consistent treatment can shift the outlook considerably in either direction. These statistics describe large groups rather than individuals, and several critical details explain why your personal trajectory may look very different, so see below to understand more. If you are experiencing shortness of breath, swelling in the legs or abdomen, unusual fatigue, or a racing or irregular heartbeat, understanding those signals early is one of the strongest levers you have over your long-term outcome. Take a free, instant, online symptom check to see what your symptoms may indicate and get clear guidance on the next steps worth discussing with a clinician.

Last reviewed for medical accuracy: 09/25/2026

answer background

Explanation

Heart Failure Life Expectancy by Age: What the Numbers Really Mean

Heart failure is a chronic condition where the heart can’t pump blood as well as it should. Many factors influence how long someone will live with heart failure, and age is one of the most important. Below, we break down the data on life expectancy by age, explain what these numbers really mean, and offer practical steps you can take today.

How Life Expectancy Is Measured

Researchers use large, long-term studies and clinical registries to estimate survival rates in people with heart failure. Some key metrics include:

  • 1-Year Mortality: The percentage of patients who die within one year of diagnosis or hospitalization.
  • 5-Year Mortality: The percentage of patients who die within five years.
  • Median Survival: The time at which half the study population is still alive.
  • NYHA Functional Class: This scale (I–IV) gauges symptoms from mild (I) to severe (IV). Higher class generally means shorter life expectancy.

Credible sources include:

  • American Heart Association (AHA)
  • European Society of Cardiology (ESC)
  • Large cohort studies like the Framingham Heart Study

Life Expectancy by Age Group

Below are approximate survival rates drawn from multiple registries and peer-reviewed studies. Keep in mind individual factors can shift these numbers up or down.

Age at Diagnosis 1-Year Survival 5-Year Survival Median Survival
Under 65 85–90% 60–70% 5–7 years
65–74 75–85% 45–60% 4–6 years
75 and Older 60–75% 30–45% 2–4 years

Sources: AHA, ESC, journal of the American College of Cardiology.

Key Takeaways by Age

  • Under 65
    • Generally the best outlook, especially if detected early
    • Aggressive treatments (medications, devices, lifestyle changes) often extend life significantly

  • Ages 65–74
    • Moderate prognosis; comorbidities (diabetes, kidney disease) start to play a larger role
    • Optimizing medication and monitoring is crucial

  • 75 and Older
    • Higher mortality rates, particularly if in NYHA class III–IV
    • Focus often shifts to quality of life and symptom management

What Influences These Numbers?

Age is just one piece of the puzzle. Other factors affecting heart failure life expectancy include:

  • NYHA Functional Class
    • Class I–II: Milder symptoms, better outlook
    • Class III–IV: More symptoms, higher risk of hospitalization and death

  • Ejection Fraction (EF)
    • Preserved EF (≥50%) vs. reduced EF (<40%)—each has different treatment pathways and survival curves

  • Comorbid Conditions
    • Diabetes, chronic kidney disease, lung disease, and anemia can each worsen prognosis

  • Lifestyle and Treatment Adherence
    • Regular exercise, low salt diet, medication compliance, weight management

  • Device Therapy
    • Pacemakers, defibrillators, and, in some cases, ventricular assist devices can extend life

Interpreting the Data Without Panic

Numbers can feel alarming, but remember:

  • These statistics represent large groups, not individual destinies.
  • Advances in treatment continue to improve outcomes year by year.
  • Early detection and proactive care make a real difference.

If you’re experiencing new or worsening symptoms—like increased shortness of breath, swelling in the legs, rapid weight gain, or chest pain—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a simple first step to see if you need urgent medical care.

Steps to Improve Your Outlook

Taking an active role in your heart health can change the odds in your favor:

  1. Work Closely with Your Care Team

    • Discuss your NYHA class and what you can expect
    • Ask about new medications or device options
  2. Optimize Medications

    • ACE inhibitors or ARBs
    • Beta-blockers
    • Mineralocorticoid receptor antagonists
    • SGLT2 inhibitors (emerging evidence shows benefit)
  3. Adopt Heart-Healthy Habits

    • Low-sodium diet (<2,000 mg/day)
    • Regular, moderate exercise (as advised)
    • Maintain a healthy weight
  4. Monitor Yourself at Home

    • Daily weight checks
    • Track blood pressure and symptoms
    • Report changes early
  5. Stay Up to Date with Regular Testing

    • Echocardiograms to check ejection fraction
    • Blood tests for kidney function and electrolytes
    • Cardiac rhythm monitoring if you have arrhythmias

When to Seek Urgent Help

Some signs that require prompt medical attention include:

  • Sudden, severe shortness of breath
  • Chest pain or pressure lasting more than a few minutes
  • Fainting or near-fainting spells
  • Swelling that worsens rapidly

If any of these occur, call emergency services immediately. Otherwise, use the Ubie Symptom Checker or contact your doctor for guidance.

Final Thoughts

Life expectancy numbers—while sobering—are only one part of your journey with heart failure. Many people live well beyond benchmark figures thanks to advances in care and active self-management. Remember:

  • Everyone’s situation is unique; talk to your doctor about your specific prognosis.
  • Use tools like the Ubie Symptom Checker to stay on top of changes.
  • Proactive lifestyle changes and adherence to therapy can significantly improve your outlook.

If you have concerns about heart failure or notice new or worsening symptoms, please speak to a doctor or other qualified healthcare professional right away. Your care team can tailor a plan that’s right for you and help you navigate the path ahead.

(References)

  • * Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities. JACC Heart Fail. 2018 May;6(5):401-409. doi: 10.1016/j.jchf.2017.12.006. Epub 2018 Mar 7. PMID: 29525333; PMCID: PMC5935537.

  • * Droege F, Thangavelu K, Stuck BA, Stang A, Lang S, Geisthoff U. Life expectancy and comorbidities in patients with hereditary hemorrhagic telangiectasia. Vasc Med. 2018 Aug;23(4):377-383. doi: 10.1177/1358863X18767761. Epub 2018 May 20. PMID: 29781402.

  • * Gouveia M, Ascenção R, Fiorentino F, Costa J, Caldeira D, Broeiro-Gonçalves P, Fonseca C, Borges M. The current and future burden of heart failure in Portugal. ESC Heart Fail. 2019 Apr;6(2):254-261. doi: 10.1002/ehf2.12399. Epub 2019 Jan 8. PMID: 30620150; PMCID: PMC6437427.

  • * Drozd M, Relton SD, Walker AMN, Slater TA, Gierula J, Paton MF, Lowry J, Straw S, Koshy A, McGinlay M, Simms AD, Gatenby VK, Sapsford RJ, Witte KK, Kearney MT, Cubbon RM. Association of heart failure and its comorbidities with loss of life expectancy. Heart. 2021 Sep;107(17):1417-1421. doi: 10.1136/heartjnl-2020-317833. Epub 2020 Nov 5. PMID: 33153996; PMCID: PMC8372397.

  • * Limpens MAM, Asllanaj E, Dommershuijsen LJ, Boersma E, Ikram MA, Kavousi M, Voortman T. Healthy lifestyle in older adults and life expectancy with and without heart failure. Eur J Epidemiol. 2022 Feb;37(2):205-214. doi: 10.1007/s10654-022-00841-0. Epub 2022 Jan 27. PMID: 35083603; PMCID: PMC8960597.

  • * Hariharaputhiran S, Peng Y, Ngo L, Ali A, Hossain S, Visvanathan R, Adams R, Chan W, Ranasinghe I. Long-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand. Eur J Heart Fail. 2022 Sep;24(9):1519-1528. doi: 10.1002/ejhf.2595. Epub 2022 Aug 2. PMID: 35748124; PMCID: PMC9804480.

  • * Yan T, Zhu S, Yin X, Xie C, Xue J, Zhu M, Weng F, Zhu S, Xiang B, Zhou X, Liu G, Ming Y, Zhu K, Wang C, Guo C. Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study. J Am Heart Assoc. 2023 Mar 21;12(6):e027852. doi: 10.1161/JAHA.122.027852. Epub 2023 Mar 9. PMID: 36892088; PMCID: PMC10111559.

  • * Weintraub WS, Kolm P, Dolman S, Alva M, Bhatt DL, Zhang Z. Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF. JACC Heart Fail. 2024 Sep;12(9):1600-1610. doi: 10.1016/j.jchf.2024.04.018. Epub 2024 Jun 12. PMID: 38878007.

  • * Stronati G, Alfieri M, Tombolesi N, Barbarossa A, Principi S, Gullì F, Massari A, Bastianoni G, Roccetti F, Casella M, Dello Russo A, Guerra F. Long-term prognosis of pure and impure tachycardiomyopathy. ESC Heart Fail. 2025 Dec;12(6):4288-4298. doi: 10.1002/ehf2.15444. Epub 2025 Oct 9. PMID: 41065522; PMCID: PMC12719866.

  • * Agostoni P, Galotta A, Salvioni E, Mapelli M, Emdin M, Piepoli M, Palazzuoli A, Sinagra G, Magrì D, Paolillo S, Passantino A, Campodonico J, Corrà U, Raimondo R, Cittadini A, Iorio A, Salzano A, Badagliacca R, Senni M, Filardi PP, Correale M, Perna E, Metra M, Vignati C, Contini M, Baracchini N, Cattadori G, Guazzi M, Limongelli G, Parati G, Pezzuto B, Willixhofer R, Palermo P, Apostolo A, Matassini MV, Bandera F, Bussotti M, Re F, Scardovi AB, Sciomer S, Girola D, Passino C, La Valle F, Puttini F, Adamo L. MECKI score thresholds for heart transplantation referral of ambulatory heart failure patients. ESC Heart Fail. 2026 Feb 3;13(1). doi: 10.1093/eschf/xvaf033. PMID: 41711709; PMCID: PMC13108268.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.